|
|
 |
|
Viewing report
|
|
|
|
Clinical Challenges in Lipid Disorders
Clinical Publishing, June 2008, Pages: 304
Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovascular disease is one of the most intensively studied issues in all of medicine. This volume is an innovative approach to the identification and management of lipid disorders. Organized as a series of questions, each chapter presents a detailed yet accessible discussion of the problems posed. The questions discussed are among the most frequently encountered at both primary care and specialty conferences throughout the world. Carefully weighing the risks and benefits of specific therapies, the ensuing discourse presents a fair, balanced approach to conceptual controversies as well as exploring the diagnostic and therapeutic dilemmas that may arise. This book is designed for the busy clinical practitioner who is in search of authoritative discussion that is balanced by evidence-based, best practice recommendations. It is intended as a resource for practitioners of primary care, cardiology, and endocrinology.
Benefits:
- Complex manifestations of lipid disorders reviewed
- Alternative management strategies presented
- Treatment options for specific patient groups / 'what if' scenarios presented
Readership:
- Cardiologists
- Endocrinologists
- Nephrologists
- General physicians
- Doctors in training
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Therapeutic Strategies in Lipid Disorders
Textbook of Diabetes, 4th Edition
Cholesterol & Other Cardiovascular Testing - Global Strategic Business Report
The Year in Lipid Disorders Volume 2
Market and Product Forecasts: Antidyslipidemics - Set for the impact of generic Lipitor
Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011
Metabolic Risk for Cardiovascular Disease
Therapeutic Strategies in Diabetes
Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects
Nitric Oxide - Therapeutics, Markets and Companies
|
|
|
|
